Total Payments
$1,384
2024 Payments
$499.36
Companies
33
Transactions
53
Medicare Patients
3,637
Medicare Billing
$591,125
Payment Breakdown by Category
Food & Beverage$1,368 (98.8%)
Education$15.96 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,368 | 52 | 98.8% |
| Education | $15.96 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novocure Inc. | $371.44 | 5 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $94.04 | 5 | $0 (2024) |
| Seagen Inc. | $74.67 | 4 | $0 (2023) |
| icotec Medical Inc. | $57.90 | 2 | $0 (2023) |
| Ion Beam Applications S.A. | $51.00 | 1 | $0 (2019) |
| Merck Sharp & Dohme LLC | $49.09 | 2 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $48.73 | 2 | $0 (2023) |
| Eisai Inc. | $47.30 | 2 | $0 (2024) |
| Janssen Biotech, Inc. | $45.63 | 2 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $44.68 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $499.36 | 25 | AstraZeneca Pharmaceuticals LP ($73.65) |
| 2023 | $391.91 | 17 | Seagen Inc. ($55.96) |
| 2022 | $64.56 | 3 | icotec Medical Inc. ($30.33) |
| 2020 | $57.91 | 3 | Novocure Inc. ($21.60) |
| 2019 | $212.67 | 3 | Novocure Inc. ($161.67) |
| 2018 | $157.70 | 2 | Novocure Inc. ($139.72) |
All Payment Transactions
53 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.87 | General |
| 12/12/2024 | Janssen Biotech, Inc. | RYBREVANT (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Oncology | ||||||
| 11/14/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: Oncology | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.51 | General |
| 10/10/2024 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Oncology | ||||||
| 10/10/2024 | MEDTEC LLC | — | Food and Beverage | Cash or cash equivalent | $16.99 | General |
| 09/19/2024 | Lilly USA, LLC | VERZENIO (Drug), RETEVMO, JAYPIRCA | Food and Beverage | In-kind items and services | $18.21 | General |
| Category: Oncology | ||||||
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $17.90 | General |
| 08/22/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $15.96 | General |
| Category: ONCOLOGY | ||||||
| 08/16/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: ONCOLOGY | ||||||
| 08/08/2024 | Genentech USA, Inc. | Columvi (Biological), Lunsumio, Polivy | Food and Beverage | In-kind items and services | $28.45 | General |
| Category: BioOncology | ||||||
| 07/16/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2024 | Karyopharm Therapeutics Inc. | XPOVIO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 06/27/2024 | Incyte Corporation | MONJUVI (Drug) | Food and Beverage | Cash or cash equivalent | $18.01 | General |
| Category: Oncology | ||||||
| 06/17/2024 | Blueprint Medicines Corporation | AYVAKIT (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Oncology / Rare Diseases | ||||||
| 05/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug), Odomzo | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Oncology | ||||||
| 05/23/2024 | Mevion_Medical_Systems_Inc | PTS250 (Device) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Proton Therapy for cancer treatment | ||||||
| 04/30/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $24.34 | General |
| Category: Oncology | ||||||
| 04/25/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $28.25 | General |
| Category: ONCOLOGY | ||||||
| 04/18/2024 | Novartis Pharmaceuticals Corporation | Fabhalta (Drug) | Food and Beverage | In-kind items and services | $20.45 | General |
| Category: Immunology | ||||||
| 04/17/2024 | GENZYME CORPORATION | SARCLISA (Biological) | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Oncology | ||||||
| 03/18/2024 | Myriad Genetic Laboratories, Inc. | MYRISK (Device) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: ONCOLOGY | ||||||
| 02/29/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $22.37 | General |
| 02/16/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 770 | 1,487 | $873,178 | $107,913 |
| 2022 | 18 | 813 | 2,113 | $968,462 | $126,838 |
| 2021 | 19 | 805 | 2,241 | $983,905 | $143,643 |
| 2020 | 20 | 1,249 | 3,101 | $1.0M | $212,732 |
Total Patients
3,637
Total Services
8,942
Medicare Billing
$591,125
Procedure Codes
80
All Medicare Procedures & Services
80 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2023 | 62 | 125 | $132,672 | $17,735 | 13.4% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2023 | 115 | 383 | $120,860 | $12,992 | 10.7% |
| 77263 | Complex radiation therapy planning | Facility | 2023 | 82 | 83 | $98,450 | $10,531 | 10.7% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2023 | 80 | 215 | $90,004 | $9,716 | 10.8% |
| 77778 | Complex application of radiation source | Facility | 2023 | 24 | 24 | $61,241 | $8,493 | 13.9% |
| 77435 | Management of cranial lesion surgery using radiation over multiple sessions | Facility | 2023 | 14 | 14 | $60,304 | $6,923 | 11.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 37 | 37 | $27,023 | $5,054 | 18.7% |
| 77295 | 3d radiation therapy planning | Facility | 2023 | 31 | 31 | $47,408 | $5,009 | 10.6% |
| 77301 | High precision radiation therapy planning | Facility | 2023 | 15 | 16 | $37,104 | $5,006 | 13.5% |
| 77334 | Design and construction of complex radiation treatment device | Office | 2023 | 11 | 45 | $18,135 | $4,102 | 22.6% |
| 77290 | Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved | Facility | 2023 | 65 | 65 | $37,639 | $4,037 | 10.7% |
| 77300 | Calculation of radiation therapy dose | Facility | 2023 | 46 | 160 | $32,780 | $3,929 | 12.0% |
| 77338 | Design and construction of radiation treatment device for high precision radiation therapy | Facility | 2023 | 15 | 16 | $20,096 | $2,686 | 13.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 21 | 22 | $11,140 | $2,422 | 21.7% |
| G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | Facility | 2023 | 54 | 151 | $22,249 | $2,395 | 10.8% |
| 77470 | Special radiation treatment | Facility | 2023 | 26 | 26 | $17,395 | $2,149 | 12.4% |
| 77318 | Complex radiation therapy planning for delivery of internal radiation | Facility | 2023 | 18 | 18 | $19,304 | $2,116 | 11.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 15 | 15 | $8,538 | $1,434 | 16.8% |
| 77280 | Obtaining data needed to develop the optimal radiation treatment, 1 treatment area | Facility | 2023 | 39 | 41 | $10,836 | $1,183 | 10.9% |
| 77427 | Radiation treatment management, 5 treatment sessions | Facility | 2022 | 82 | 183 | $184,338 | $26,640 | 14.5% |
| 77014 | Ct guidance for insertion of radiation therapy fields | Facility | 2022 | 90 | 572 | $172,786 | $19,737 | 11.4% |
| 77334 | Design and construction of complex radiation treatment device | Facility | 2022 | 87 | 253 | $100,711 | $11,858 | 11.8% |
| 77263 | Complex radiation therapy planning | Facility | 2022 | 82 | 84 | $94,901 | $10,824 | 11.4% |
| 77301 | High precision radiation therapy planning | Facility | 2022 | 26 | 26 | $57,300 | $8,475 | 14.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 49 | 49 | $33,759 | $6,973 | 20.7% |
About Dr. Michael Confer, M.D
Dr. Michael Confer, M.D is a Radiation Oncology healthcare provider based in West Plains, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1336346337.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Confer, M.D has received a total of $1,384 in payments from pharmaceutical and medical device companies, with $499.36 received in 2024. These payments were reported across 53 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($1,368).
As a Medicare-enrolled provider, Confer has provided services to 3,637 Medicare beneficiaries, totaling 8,942 services with total Medicare billing of $591,125. Data is available for 4 years (2020–2023), covering 80 distinct procedure/service records.
Ad
Practice Information
- Specialty Radiation Oncology
- Other Specialties Radiation Oncology
- Location West Plains, MO
- Active Since 07/02/2007
- Last Updated 01/13/2026
- Taxonomy Code 2085R0001X
- Entity Type Individual
- NPI Number 1336346337
Products in Payments
- Oncology (Device) $322.99
- PADCEV (Biological) $61.09
- KEYTRUDA (Biological) $49.09
- ORGOVYX (Drug) $48.73
- Optune (Device) $48.45
- Lenvima (Drug) $47.30
- LIBTAYO (Biological) $35.96
- SARCLISA (Biological) $30.95
- icotec Medical BlackArmor Spine Oncology System (Device) $30.33
- Columvi (Biological) $28.45
- icotec BlackArmor Spine System (Device) $27.57
- IMBRUVICA (Drug) $26.36
- DARZALEX (Biological) $25.95
- Doptelet (Drug) $25.47
- PROMACTA (Drug) $24.23
- Stivarga (Drug) $23.33
- AYVAKIT (Drug) $21.30
- Fabhalta (Drug) $20.45
- LYNPARZA (Drug) $20.39
- FRUZAQLA (Drug) $20.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.